Merck Rises, Bristol-Myers Slides Following Cancer Meeting
Shares of Merck (MRK) are rising this morning, while peer Bristol-Myers (BMY) is sliding, after both companies presented new data on their respective cancer immunotherapy treatments at the American Association for Cancer Research annual meeting that began over this weekend. MERCK’S KEYTRUDA: In conjunction with the AACR meeting, Merck announced results from KEYNOTE-189, a pivotal…